A. Pena

发表

New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.

G. Montalescot, J. Collet, D. Brieger, 2010, Journal of the American College of Cardiology.

Platelet Protease Nexin-1, a Serpin That Strongly Influences Fibrinolysis and Thrombolysis

J. Collet, B. Ho-Tin-Noé, B. Richard, 2010, Circulation.

FXIII-A Leu34 genetic variant in premature coronary artery disease: A genotype – phenotype case control study

J. Weisel, G. Montalescot, J. Hulot, 2011, Thrombosis and Haemostasis.

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

G. Montalescot, J. Hulot, J. Collet, 2011, JACC. Cardiovascular interventions.

Altered fibrin clot structure/function and FXIII Leu34 genetic variant in patients with premature coronary artery disease

J. Weisel, J. Silvain, G. Cayla, 2012 .

Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.

G. Montalescot, D. Costagliola, J. Collet, 2010, Journal of the American College of Cardiology.

Can we override clopidogrel resistance?

G. Montalescot, J. Hulot, J. Collet, 2009, Circulation.

Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study.

G. Montalescot, J. Collet, D. Brieger, 2010, European heart journal.

Composition of coronary thrombus in acute myocardial infarction.

J. Weisel, G. Montalescot, J. Collet, 2011, Journal of the American College of Cardiology.

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.

G. Montalescot, J. Hulot, J. Collet, 2010, Journal of the American College of Cardiology.

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Deepak L. Bhatt, E. Vicaut, H. Drexler, 2010, The American journal of cardiology.

Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure

J. Ruidavets, A. Bura, G. Montalescot, 2011, Thrombosis and Haemostasis.

Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose: The Reload With Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term With Dual Antiplatelet Therapy (RELOAD) Study

G. Montalescot, J. Collet, J. Silvain, 2008, Circulation.

Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P 450 2 C 19 * 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration

G. Montalescot, J. Hulot, J. Collet, 2022 .

New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.

G. Montalescot, J. Collet, D. Brieger, 2010, Journal of the American College of Cardiology.

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.

G. Montalescot, J. Hulot, J. Collet, 2010, Journal of the American College of Cardiology.